This inventor holds 1 USPTO granted patent and 1 published patent application, plus 6 CIPO patents and 41 EPO patents. Top assignee: Biomerieux, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Paul Mcpherson - Innovator in Kidney Injury Assessment
Introduction
Paul Mcpherson is an inventor based in Encinitas, CA (US). He has made significant contributions to the field of medical research, particularly in assessing and treating kidney injuries. Although he currently holds no granted patents, his work is noteworthy for its potential impact on healthcare.
Latest Patent Applications
One of Paul Mcpherson's notable patent applications is titled "Methods and Compositions for Assessing and Treating Persistent Acute Kidney Injury Based on C-C Motif Chemokine Ligand 14 Measurement." This invention relates to methods and compositions for assessing the risk of developing persistent acute kidney injury. It also includes methods for treating a subject based on the assessment. The application specifically discusses the detection of C-C motif chemokine ligand 14 (CCL14) for predicting the risk of persistent acute kidney injury. This is based on changes in the level of CCL14 in two or more measurements and/or based on two cutoff levels of CCL14.
Conclusion
Paul Mcpherson's innovative work in the field of kidney injury assessment highlights his commitment to advancing medical research. His contributions, although not yet patented, show promise for future developments in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile